Isomerization of Asp-Asp motif in model peptides and a monoclonal antibody fab fragment

Journal of Pharmaceutical Sciences

Volumn 102, Issue 3, 2013, Pages 947-959

  Yi, Li ^a   Beckley, Nia ^a   Gikanga, Benson ^a   Zhang, Jennifer ^a   Wang, Y John ^a   Chih, Hung Wei ^a   Sharma, Vikas K ^a  

^a GENENTECH INC   (United States)

Author keywords

Asp Asp motifs; Isomerization; Kinetics; Monoclonal antibody Fab

Indexed keywords

ASPARTIC ACID; HEXAPEPTIDE; IMMUNOGLOBULIN F(AB) FRAGMENT;

ARTICLE; DEGRADATION; ISOMERIZATION; PH;

EID: 84878146568     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23423     Document Type: Article

References (36)

1. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. 2010. Stability of protein pharmaceuticals: An update. Pharm Res 27(4):544-575.
2. Bernhard SA, Berger A, Carter JH, Katchalski E, Sela M, Shalitin Y. 1962. Cooperative effects of functional groups in peptides. I. Aspartyl-serine derivatives. J Am Chem Soc 84:2421-2434.
3. Bodanszky M, Natarajan S. 1975. Side reactions in peptide synthesis. II. Formation of succinimide derivatives from aspartyl residues. J Org Chem 40(17):2495-2499.
4. Geiger T, Clarke S. 1987. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J Biol Chem 262(2):785-794.
5. Robinson NE, Robinson AB. 2004. Molecular clocks: Deamidation of asparaginyl and glutaminyl residues in peptides and proteins. Cave Junction, Oregon: Althouse Press.
6. Harris RJ, Kabakoff B, Macchi FD, Shen FJ, Kwong M, Andya JD, Shire SJ, Bjork N, Totpal K, Chen AB. 2001. Identification of multiple sources of charge heterogeneity in a recombinant antibody. J Chromatogr B 752(2):233-245.
7. Wakankar AA, Borchardt RT, Eigenbrot C, Shia S, Wang YJ, Shire SJ, Liu JL. 2007. Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies. Biochemistry 46(6):1534-1544.
8. Tsuda T, Uchiyama M, Sato T, Yoshino H, Tsuchiya Y, Ishikawa S, Ohmae M, Watanabe S, Miyake Y. 1990. Degradation peptides of secretin after storage in acid and neutral aqueous solutions. J Pharm Sci 79(1):53-56.
9. Cacia J, Keck R, Presta LG, Frenz J. 1996. Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: Identification and effect on binding affinity. Biochemistry 35(6):1897-1903.
10. Oliyai C, Borchardt RT. 1993. Chemical pathways of peptide degradation. IV. Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide. Pharm Res 10(1):95-102.
11. Oliyai C, Borchardt RT. 1994. Chemical pathways of peptide degradation. VI. Effect of the primary sequence on the pathways of degradation of aspartyl residues in model hexapeptides. Pharm Res 11(5):751-758.
12. Bongers J, Heimer EP, Lambros T, Pan YC, Campbell RM, Felix AM. 1992. Degradation of aspartic acid and asparagine residues in human growth hormone-releasing factor. Int J Pept Protein Res 39(4):364-374.
13. Johnson BA, Shirokawa JM, Hancock WS, Spellman MW, Basa LJ, Aswad DW. 1989. Formation of isoaspartate at two distinct sites during in vitro aging of human growth hormone. J Biol Chem 264(24):14262-14271.
14. Kirsch LE, Molloy RM, Debono M, Baker P, Farid KZ. 1989. Kinetics of the aspartyl transpeptidation of daptomycin, a novel lipopeptide antibiotic. Pharm Res 6(5):387-393.
15. Radkiewicz JL, Zipse H, Clarke S, Houk KN. 2001. Neighboring side chain effects on asparaginyl and aspartyl degradation: An ab initio study of the relationship between peptide conformation and backbone NH acidity. J Am Chem Soc 123(15):3499-3506.
16. Stephenson RC, Clarke S. 1989. Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins. J Biol Chem 264(11):6164-6170.
17. Bodanszky M, Kwei JZ. 1978. Side reactions in peptide synthesis. VII. Sequence dependence in the formation of aminosuccinyl derivatives from beta-benzyl-aspartyl peptides. Int J Pept Protein Res 12(2):69-74.
18. Brennan TV, Clarke S. 1995. Effect of adjacent histidine and cysteine residues on the spontaneous degradation of asparaginyl-containing and aspartyl-containing peptides. Int J Pept Protein Res 45(6):547-553.
19. Rehder DS, Chelius D, McAuley A, Dillon TM, Xiao G, Crouse-Zeineddini J, Vardanyan L, Perico N, Mukku V, Brems DN, Matsumura M, Bondarenko PV. 2008. Isomerization of a single aspartyl residue of anti-epidermal growth factor receptor immunoglobulin gamma 2 antibody highlights the role avidity plays in antibody activity. Biochemistry 47(8):2518-2530.
20. Wakankar AA, Borchardt RT. 2006. Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization. J Pharm Sci 95(11):2321-2336.
21. Brennan TV, Clarke S. 1993. Spontaneous degradation of polypeptides at aspartyl and asparaginyl residues-Effects of the solvent dielectric. Protein Sci 2(3):331-338.
22. Xiao G, Bondarenko PV. 2008. Identification and quantification of degradations in the Asp-Asp motifs of a recombinant monoclonal antibody. J Pharm Biomed Anal 47(1):23-30.
23. Zhang J, Yip H, Katta V. 2011. Identification of isomerization and racemization of aspartate in the Asp-Asp motifs of a therapeutic protein. Anal Biochem 410(2):234-243.
24. Ellis KJ, Morrison JF. 1982. Buffers of constant ionic strength for studying pH-dependent processes. Methods Enzymol 87:405-426.
25. Dawson RMC. 1986. Data for biochemical research. Oxford: Clarendon Press.
26. Amano M, Hasegawa J, Kobayashi N, Kishi N, Nakazawa T, Uchiyama S, Fukui K. Specific racemization of heavy-chain cysteine-220 in the hinge region of immunoglobulin gamma 1 as a possible cause of degradation during storage. Anal Chem 83(10):3857-3864.
27. Conrad U, Fahr A, Scriba GKE. 2010. Kinetics of aspartic acid isomerization and enantiomerization in model aspartyl tripeptides under forced conditions. J Pharm Sci 99(10):4162-4173.
28. De Boni S, Oberthur C, Hamburger M, Scriba GK. 2004. Analysis of aspartyl peptide degradation products by high-performance liquid chromatography and high-performance liquid chromatography-mass spectrometry. J Chromatogr A 1022(1-2):95-102.
29. Sadakane Y, Fujii N, Nakagomi K. 2011. Determination of rate constants for β-linkage isomerization of three specific aspartyl residues in recombinant human αA-crystallin protein by reversed-phase HPLC. J Chromatogr B, Anal Technol Biomed Life Sci 879(29):3240-3246.
30. Capasso S, Kirby AJ, Salvadori S, Sica F, Zagari A. 1995. Kinetics and mechanism of the reversible isomerization of aspartic acid residues in tetrapeptides. J Chem Soc, Perkin Trans 2(3):437-442.
31. Capasso S, Mazzarella L, Zagari A. 1991. Deamidation via cyclic imide of asparaginyl peptides: Dependence on salts, buffers and organic solvents. Peptide Res 4(4):234-238.
32. Patel K, Borchardt RT. 1990. Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide. Pharm Res 7(7):703-711.
33. Li B, Gorman EM, Moore KD, Williams T, Schowen RL, Topp EM, Borchardt RT. 2005. Effects of acidic N + 1 residues on asparagine deamidation rates in solution and in the solid state. J Pharm Sci 94(3):666-675.
34. Yu XC, Joe K, Zhang Y, Adriano A, Wang Y, Gazzano-Santoro H, Keck RG, Deperalta G, Ling V. 2011. Accurate determination of succinimide degradation products using high fidelity trypsin digestion peptide map analysis. Anal Chem 83(15):5912-5919.
35. Sinha S, Zhang L, Duan S, Williams TD, Vlasak J, Ionescu R, Topp EM. 2009. Effect of protein structure on deamidation rate in the Fc fragment of an IgG1 monoclonal antibody. Protein Sci 18(8):1573-1584.
36. Xie M, Schowen RL. 1999. Secondary structure and protein deamidation. J Pharm Sci 88(1):8-13.